Amcor (AMCR) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
12 Aug, 2026Executive summary
Q4 adjusted EPS rose 23% year-over-year to $1.23, and full-year adjusted EPS increased 13% to $4.02, with strong operating performance and synergy capture exceeding targets.
Net sales for Q4 2026 reached $6.4 billion, up 26% year-over-year, and full-year net sales were $23.5 billion, up 57%, driven by the Berry acquisition and higher raw material cost pass-through.
Synergies delivered in FY26 totaled $285 million, 10% ahead of initial expectations, reaffirming a $650 million three-year target.
Five divestitures closed in H2 FY26, sharpening focus on higher-growth, higher-return core businesses, with improved non-core performance.
Free cash flow for the year was $1.3 billion, impacted by Middle East conflict and integration costs, but expected to recover in the next 12 months.
Financial highlights
Q4 revenue: $6.4 billion; adjusted EBITDA: $1,045 million (16.3% margin); adjusted EBIT: $836 million (13.1% margin), all up year-over-year.
Full-year net sales: $23.5 billion; adjusted EBITDA: $3,673 million (15.6% margin); adjusted EBIT: $2,813 million (12.0% margin); adjusted EPS: $4.02 (up 13%); free cash flow: $1.3 billion.
Q4 adjusted EBIT was $836 million, up 37%, with $96 million from acquired EBIT and $100 million in synergy benefits.
Quarterly dividend increased to $0.65 per share, a 2% increase versus prior year.
Net debt at June 30, 2026 was $12,897 million.
Outlook and guidance
For the six months ending Dec 31, 2026, adjusted EPS expected in the range of $1.80–$1.90, reflecting improved operations but higher interest and tax expense.
Double-digit adjusted EPS growth targeted for calendar 2027, with leverage expected to be ~3x by year-end.
Free cash flow of ~$2.5 billion targeted for the next 12 months, including $500 million working capital recovery.
Leverage at December 31, 2026 projected at 3.5x–3.6x net debt to LTM adjusted EBITDA.
Transitioning to a December 31 year-end, with a six-month reporting period (July–December 2026).
Latest events from Amcor
- Q3 net sales rose 77% and synergy capture advanced, with portfolio optimization progressing.AMCR
Q3 2026 - Strong Q2 and H1 growth from Berry acquisition; FY26 guidance reaffirmed amid integration.AMCR
Q2 2026 - Fiscal 2024 saw strong earnings, board refreshment, and major advances in sustainability and governance.AMCR
Proxy Filing - Merger integration, strong growth, and a proposed reverse stock split headline this year's proxy.AMCR
Proxy Filing - $24B merger creates a global packaging leader with $650M synergies and strong EPS growth.AMCR
M&A Announcement - Net income up 26% to $191M on $3.35B sales, with margin gains and $122M asset sale to cut debt.AMCR
Q1 2025 - Q4 volumes returned to growth, supporting strong FY24 cash flow and a positive FY25 outlook.AMCR
Q4 2024 - Berry Global deal advances, synergies targeted, and margin growth continues amid cautious consumer trends.AMCR
Bank of America 2025 Global Agriculture and Materials Conference - Q2 net income up 22%, EPS up 23%, and Berry merger advances with $650M synergies targeted.AMCR
Q2 2025